About
GERD Treatment
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
400
By Phase
PHASE1: 1PHASE2: 1EARLY_PHASE1: 1
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05469854Lead Sponsor
A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate
PHASE1Recruiting
113 participants
Started: Jul 13, 2022 · Completed: Dec 2, 2024
NCT05055128Lead Sponsor
A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole
PHASE2Completed
248 participants
Started: Aug 11, 2021 · Completed: Sep 1, 2022
NCT03105375Lead Sponsor
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of X842 in Human: A Single/Multiple Ascending Dose Study
EARLY_PHASE1Completed
39 participants
Started: Feb 21, 2017 · Completed: Oct 12, 2017
Locations (1)
Headquarters
Stockholm, Sweden
Map
Loading map...